Application of machine learning methods in clinical trials for precision medicine is a research paper published in JAMIA Open (2022). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
US National Institutes of Health
Grant: U54CA096300
NCI NIH HHS
Grant: R03 CA270725
US National Institutes of Health
Grant: U01CA253911
NCI NIH HHS
Grant: P50 CA100632
US National Institutes of Health
Grant: 5P50CA100632
NCI NIH HHS
Grant: P50 CA070907
National Institutes of Health
Grant: 5U54CA096300-02
PRCC/MDACC: Partners for Excellence in Cancer Research
National Institutes of Health
Grant: 3P50CA100632-06S1
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
National Institutes of Health
Grant: 3U01CA253911-02S1
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum
FWCI
6.18
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals